LFCR
Lifecore Biomedical Inc.
6.50$
-0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.0% | +0.1% | +3.1% | +0.2% | -2.8% | +3.5% | -6.9% | +0.7% | -1.7% | -4.1% | +1.8% | |
| – | -6.4% | -7.4% | +22.4% | -13.7% | -8.5% | +10.3% | +2.9% | +1.7% | -2.0% | -7.5% | +7.8% | |
| – | +192.9% | -62.7% | +492.7% | -55.7% | -34.8% | +71.3% | -42.7% | +52.6% | +128.1% | +10.3% | -17.1% | |
| – | – | – | – | -55.7% | -34.8% | +71.3% | -42.7% | +52.6% | +128.1% | +10.3% | -17.1% | |
| – | -17.8% | +13.5% | -3.9% | +7.3% | -19.3% | -19.8% | -4.0% | +125.5% | -33.3% | -7.7% | +13.3% | |
| – | -14.4% | -0.6% | -1.5% | -2.1% | +4.2% | -5.8% | -11.8% | -6.7% | +4.7% | -16.7% | -9.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -4.5% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | |
| – | +28.3% | -5.7% | +5.5% | -5.9% | +3.3% | -4.3% | -1.9% | +1.1% | -16.6% | +3.2% | +4.2% | |
| – | -6.0% | +13.7% | -2.4% | -1.1% | +4.2% | -12.9% | -11.8% | -3.0% | -0.7% | -31.6% | +5.6% | |
| – | – | – | – | +165.2% | +0.2% | -0.5% | +0.1% | -21.9% | -65.6% | +1.7% | -27.4% | |
| – | +6.3% | +21.2% | +16.2% | -26.1% | +10.3% | -16.9% | -50.5% | +11.0% | +23.1% | -34.4% | +13.5% | |
| – | +8.3% | +1.7% | +6.7% | +3.7% | +5.5% | -6.4% | +4.2% | +2.4% | +6.3% | +5.3% | +4.5% | |
| – | -139.6% | – | -397.7% | – | -134.8% | – | -85.6% | -40.1% | +2,653.4% | -43.5% | -22.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +0.0% | -0.4% | +0.8% | +1.0% | +11.4% | +7.7% | +0.0% | +1.0% | +0.2% | +0.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.